The American Society of Clinical Oncology (ASCO) previously published evidencebased
guidelines for the treatment of unresectable non–small-cell lung cancer (NSCLC)[1]. ASCO …

A meta-analysis of the literature for the use of FDG PET in the detection of recurrent
colorectal cancer (CRC) was conducted to evaluate the quality of the reported studies …

The aim of that book was to address what we perceived of as a lack, at the time, of a
comprehensive contemporary reference work on the rapidly expanding area of positron …

The burden of cancer is growing, and the disease is becoming a major economic
expenditure for all developed countries. In 2008, the worldwide cost of cancer due to …

This book is written as both a text and a reference book. It contains numerous images from
the biological sciences and clinical practice, tables, graphs, and fig ures, as well as …

PURPOSE To compare the accuracy of computed tomography-(CT) scan and the
radiolabeled glucose analog 18F-fluoro-2-deoxy-D-glucose (FDG) positron emission …

Purpose: Many patients with non-small cell lung cancer (NSCLC) receive external beam
radiation therapy as part of their treatment. Three-dimensional conformal radiation therapy …

PURPOSE: To compare the accuracies of whole-body 2-[fluorine 18] fluoro-2-deoxy-d-
glucose (FDG) positron emission tomography (PET) and conventional imaging (thoracic …

▪ Abstract Whole-body positron emission tomography (PET) imaging with 18F deoxyglucose
(FDG) is a molecular imaging modality that detects metabolic alterations in tumor cells that …

Background In most malignant cells, the relatively low level of glucose-6-phosphatase leads
to accumulation and trapping of [18 F] fluorodeoxyglucose (FDG) intracellularly, allowing the …